article thumbnail

National Emergency Response Information System Launched to Modernize Incident Data Collection for American Fire Departments

NVFC

NERIS Version 1 will provide fire and EMS departments and first responders with more accurate and actionable post-incident information to better address community needs, support critical decision-making, and improve overall public safety. NERIS will replace the legacy NFIRS data system.

article thumbnail

Mary E. Meeks Selected as the 2024 – 25 Recipient of the Jack Stout EMS Fellowship for Leadership Development

FirstWatch

Meeks, EMS District Chief for Chatham Emergency Services (CES), headquartered in Savannah, Ga., has been named the 2024 – 25 recipient of the Jack Stout EMS Fellowship. Endowed by FirstWatch , the Fellowship was created in collaboration with the Fitch EMS Foundation. PLATTE CITY, MO — Mary E.

EMS 52
professionals

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Texas Residency Program Unexpectedly Announces Closure

ACEP Now

The CHRISTUS Health-Texas A&M Spohn Emergency Medicine Residency Program announced Friday that its program will close in June 2026 after the current emergency medicine residents complete their training. We feel that this decision was made without adequate assessment of the negative impacts this WILL have on our patients.

ICU 132
article thumbnail

A Conversation with ABEM President Dr. Ramon W. Johnson

ACEP Now

Dr. Dark: Our profession is composed of over 44,000 ABEM certified emergency physicians, about 96 percent of whom are EM residency trained. It won‘t launch until 2026, but we’re hoping by that time we’ll be ready to go. Our conversation has been edited for space and clarity. We want it to be valid, we want it to be reliable.

OR 59
article thumbnail

Policy Playbook: Medicare Part D Drug Pricing Negotiations

EMDocs

3 On August 29, 2023, CMS released its ten contenders for initial price applicability year 2026 – these include Eliquis, Jardiance, Xarelto, Januvia, Farxiga, Entresto, Enbrel, Imbruvica, Stelara, and multiple short-acting insulin formulations including NovoLog and Fiasp. 5 Why does it matter? 8 What can I do about it?

ED 71